Name | Number of supported studies | Average coverage | |
---|---|---|---|
pericyte | 25 studies | 33% ± 16% | |
smooth muscle cell | 23 studies | 42% ± 18% | |
oligodendrocyte | 15 studies | 39% ± 15% | |
glutamatergic neuron | 11 studies | 53% ± 25% | |
GABAergic neuron | 10 studies | 50% ± 28% | |
endothelial cell | 10 studies | 35% ± 10% | |
fibroblast | 8 studies | 35% ± 16% | |
renal alpha-intercalated cell | 7 studies | 61% ± 17% | |
oligodendrocyte precursor cell | 7 studies | 28% ± 11% | |
interneuron | 6 studies | 50% ± 24% | |
retinal ganglion cell | 6 studies | 66% ± 24% | |
cardiac muscle cell | 6 studies | 69% ± 21% | |
neuron | 5 studies | 35% ± 13% | |
amacrine cell | 5 studies | 29% ± 11% | |
Mueller cell | 5 studies | 46% ± 11% | |
OFF-bipolar cell | 4 studies | 43% ± 24% | |
muscle cell | 4 studies | 45% ± 30% | |
ionocyte | 3 studies | 27% ± 3% | |
pancreatic A cell | 3 studies | 53% ± 8% | |
glomerular endothelial cell | 3 studies | 20% ± 1% | |
GABAergic interneuron | 3 studies | 49% ± 7% | |
astrocyte | 3 studies | 37% ± 18% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 93% | 8130.26 | 2465 / 2642 | 95% | 41.39 | 673 / 705 |
kidney | 83% | 2896.12 | 74 / 89 | 93% | 75.18 | 841 / 901 |
prostate | 71% | 3212.18 | 174 / 245 | 93% | 19.16 | 467 / 502 |
breast | 72% | 2468.26 | 331 / 459 | 86% | 11.77 | 962 / 1118 |
thymus | 71% | 1958.33 | 461 / 653 | 87% | 19.67 | 525 / 605 |
lung | 81% | 2321.92 | 467 / 578 | 75% | 14.16 | 861 / 1155 |
bladder | 95% | 7099.81 | 20 / 21 | 56% | 8.14 | 282 / 504 |
stomach | 79% | 4624.87 | 285 / 359 | 70% | 13.35 | 200 / 286 |
intestine | 73% | 2387.41 | 705 / 966 | 61% | 8.87 | 319 / 527 |
esophagus | 65% | 5412.41 | 937 / 1445 | 63% | 9.60 | 116 / 183 |
ovary | 76% | 2480.77 | 136 / 180 | 52% | 5.65 | 223 / 430 |
uterus | 77% | 2743.88 | 131 / 170 | 32% | 6.87 | 146 / 459 |
blood vessel | 100% | 24704.96 | 1334 / 1335 | 0% | 0 | 0 / 0 |
heart | 94% | 11656.55 | 812 / 861 | 0% | 0 | 0 / 0 |
pancreas | 2% | 28.91 | 5 / 328 | 93% | 19.92 | 165 / 178 |
muscle | 93% | 6137.04 | 750 / 803 | 0% | 0 | 0 / 0 |
skin | 43% | 1309.99 | 777 / 1809 | 45% | 10.60 | 211 / 472 |
adrenal gland | 4% | 84.16 | 11 / 258 | 76% | 26.87 | 175 / 230 |
adipose | 79% | 4227.01 | 957 / 1204 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 40% | 4.39 | 18 / 45 |
liver | 2% | 33.96 | 4 / 226 | 38% | 5.96 | 154 / 406 |
lymph node | 0% | 0 | 0 / 0 | 24% | 4.21 | 7 / 29 |
eye | 0% | 0 | 0 / 0 | 21% | 3.19 | 17 / 80 |
spleen | 8% | 168.58 | 20 / 241 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0019722 | Biological process | calcium-mediated signaling |
GO_0005575 | Cellular component | cellular_component |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0008597 | Molecular function | calcium-dependent protein serine/threonine phosphatase regulator activity |
GO_0003676 | Molecular function | nucleic acid binding |
Gene name | RCAN2 |
Protein name | Calcipressin-2 (Down syndrome candidate region 1-like 1) (Myocyte-enriched calcineurin-interacting protein 2) (MCIP2) (Regulator of calcineurin 2) (Thyroid hormone-responsive protein ZAKI-4) Calcipressin-2 (Regulator of calcineurin 2) Alternative protein RCAN2 |
Synonyms | ZAKI4 DSCR1L1 |
Description | FUNCTION: Inhibits calcineurin-dependent transcriptional responses by binding to the catalytic domain of calcineurin A. Could play a role during central nervous system development. FUNCTION: Inhibits calcineurin-dependent transcriptional responses by binding to the catalytic domain of calcineurin A. Could play a role during central nervous system development. . |
Accessions | L0R6N1 Q86YJ0 ENST00000306764.11 [Q14206-2] ENST00000330430.10 [Q14206-1] ENST00000371374.6 [Q14206-2] Q14206 |